Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3530761 | 0.83 | — | — | |
| SCHEMBL793316 | 0.75 | TSHR (0.41) | — | |
| SCHEMBL7533426 | 0.72 | — | — | |
| SCHEMBL200514 | 0.71 | GPR3 (0.45) | GPR3 | |
| SCHEMBL2469503 | 0.71 | — | — | |
| SCHEMBL9588618 | 0.71 | — | — | |
| SCHEMBL4603091 | 0.70 | HDAC4 (0.41) | — | |
| SCHEMBL3292005 | 0.67 | — | — | |
| SCHEMBL351335 | 0.67 | NOTUM (0.32) | — | |
| SCHEMBL351151 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024128305-A1 | 2-AZABICYCLO[3.1.1]HEPTANE COMPOUND | 第一三共株式会社 | 2024-06-20 | — | — | WO | claimed |
| CN-118201911-A | Compounds and their use as GPR183 inhibitors | 南京艾美斐生物医药科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-20230381142-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-30 | — | — | US | claimed |
| WO-2023230217-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2023-11-30 | — | — | WO | claimed |
| EP-3741757-B1 | DIHYDROINDOLIZINONE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2023-07-26 | — | — | EP | claimed |
| US-11530211-B2 | Dihydroindolizinone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2022-12-20 | — | — | US | claimed |
| CN-109923116-B | [1,2,4] triazolo [1,5-a ] pyrimidine derivatives as PDE2 inhibitors | 詹森药业有限公司 | 2022-12-06 | — | — | CN | claimed |
| EP-3998107-A1 | METHOD FOR PRODUCING INSULIN-PRODUCING CELL USING DIHYDROINDOLIZINONE DERIVATIVES | Tokyo Institute of Technology (JP) | 2022-05-18 | — | — | EP | claimed |
| EP-3957636-A1 | FUNGICIDAL OXADIAZOLES | FMC Corporation (US) | 2022-02-23 | — | — | EP | claimed |
| CN-114040966-A | Method for producing insulin-producing cell using dihydroindolizinone derivative | 国立大学法人东京工业大学 | 2022-02-11 | — | — | CN | claimed |
| WO-1998043480-A1 | FUNGICIDE COMPOSITIONS CONTAINING A 3-PHENYL-PYRAZOLE | RHONE-POULENC AGRO (FR) | 1998-10-08 | — | — | WO | claimed |
| US-5536725-A | Insecticidal substituted-2,4-diamino-5,6,7,8-tetrahydroquinazolines | FMC CORPORATION (US) | 1996-07-16 | — | — | US | claimed |
| EP-0505742-A2 | Process for the production of 4-cyanopyrrole compounds substituted at the 3-position | BAYER AG (DE) | 1992-09-30 | — | — | EP | claimed |
| US-4897416-A | 5-OXIMINO-13B-CARBONYLTHIOMILBEMYCIN DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1990-01-30 | — | — | US | claimed |
| EP-0097425-B1 | FUNGICIDAL OR PLANT GROWTH REGULATING TRIAZOLYL ETHANOLS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1987-04-08 | — | — | EP | claimed |
| EP-0048548-B1 | PHARMACEUTICAL COMPOSITIONS OF FUNGICIDAL TRIAZOLE DERIVATIVES | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-11-14 | — | — | EP | claimed |
| EP-0097425-A2 | Fungicidal or plant growth regulating triazolyl ethanols | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-01-04 | — | — | EP | claimed |
| US-4344960-A | Combating insects and acarids with 3-(2-chloro-3,3,4,4,4-pentafluoro-1-butenyl)-2,2-dimethyl-cyclopropanecarboxylic acid esters | BAYER AKTIENGESELLSCHAFT (DE) | 1982-08-17 | — | — | US | claimed |
| EP-0048548-A1 | Pharmaceutical compositions of fungicidal triazole derivatives | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-03-31 | — | — | EP | claimed |
| EP-0040742-A1 | 3-(Chloro-3,3,4,4,4-pentafluoro-1-butenyl)-2,2-dimethylcyclopropanecarboxylic acid esters, process for their preparation and their use in insecticides | BAYER AG (DE) | 1981-12-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230381142-A1 | ANTILEISHMANIAL COMPOUNDS, COMPOSITIONS AND USE THEREOF | MPO, SSB, SGMS2 | GPR3 3949/4885 |
| US-11530211-B2 | Dihydroindolizinone derivative | INSR, GPR119, IAPP | GPR3 2463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.